Premium
Prophylaxis with low‐molecular‐weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phase
Author(s) -
Sibai Hassan,
Atenafu Eshetu G.,
Seki Jack T.
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18015
Subject(s) - low molecular weight heparin , medicine , heparin , asparaginase , gastroenterology , pharmacology , leukemia , lymphoblastic leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom